Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy

Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS

NCT04557085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Cenobamate in the Intensive Care Unit

NCT06352723 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy

NCT03796962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

NCT03678753 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

NCT00744731 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

NCT05159908 ·Status: COMPLETED ·Phase: PHASE2

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

NCT00175864 ·Status: WITHDRAWN ·Phase: PHASE3

Cenobamate Open-Label Extension Study for YKP3089C025

NCT03961568 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Cenobamate in Adults With Focal-Onset Seizures

NCT05859854 ·Status: ACTIVE_NOT_RECRUITING

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

NCT03373383 ·Status: COMPLETED ·Phase: PHASE2

Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

NCT05493293 ·Status: TERMINATED ·Phase: PHASE2

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

NCT06590896 ·Status: RECRUITING ·Phase: PHASE2

A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures

NCT00297349 ·Status: COMPLETED

REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization

NCT06922175 ·Status: RECRUITING

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

NCT03283371 ·Status: COMPLETED ·Phase: PHASE2

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

NCT04686786 ·Status: TERMINATED ·Phase: PHASE2

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2

A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis

NCT00259805 ·Status: COMPLETED ·Phase: PHASE1

The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy

NCT05748236 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4

A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

NCT00740623 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

NCT01529034 ·Status: TERMINATED ·Phase: PHASE3

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

NCT00152451 ·Status: COMPLETED ·Phase: PHASE2

Evaluation and Treatment of Patients With Epilepsy

NCT00013845 ·Status: TERMINATED

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

NCT06132893 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

NCT01142193 ·Status: COMPLETED ·Phase: PHASE3